APA (7th ed.) Citation

Jianghua Ding, Xingjing Ding, Jiao Zeng, Jiao Zeng, & Xiaoqun Liu. (2024). Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: A glittering diamond in the rough of EGFR-TKI. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jianghua Ding, Xingjing Ding, Jiao Zeng, Jiao Zeng, and Xiaoqun Liu. Furmonertinib for EGFR-mutant Advanced Non-small Cell Lung Cancer: A Glittering Diamond in the Rough of EGFR-TKI. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Jianghua Ding, et al. Furmonertinib for EGFR-mutant Advanced Non-small Cell Lung Cancer: A Glittering Diamond in the Rough of EGFR-TKI. Frontiers Media S.A., 2024.